A novel mutation of Arg306 of factor V gene in Hong Kong chinese

Blood

Volumn 91, Issue 4, 1998, Pages 1135-1139

  Chan, W P ^a   Lee, C K ^a   Kwong, Y L ^a   Lam, C K ^a   Liang, Raymond ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5;

AMINO ACID SUBSTITUTION; ARTICLE; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; DNA SEQUENCE; GENE MUTATION; HONG KONG; HUMAN; PRIORITY JOURNAL;

EID: 0032520034     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.4.1135     Document Type: Article

References (18)

1. Kalafatis M, Bertina RM, Rand MD, Mann KG: Characterization of the molecular defect in the FV R506Q. J Biol Chem 270:4053, 1995
2. Dahlback B, Carlsson M, Svensson PJ: Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90:1004, 1993
3. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM: Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden tnrombophilia study. Lancet 342:1503, 1993
4. Griffin JH, Evatt B, Wideman C, Fernandez JA: Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 82:1989, 1993
5. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH: Mutation in blood coagulation factor associated with resistance to activated protein C. Nature 369:64, 1994
6. Greengard JS, Sun X, Xu X, Fernandez JA, Griffin JH, Evatt B: Activated protein C resistance caused by Arg506 Gln mutation in factor Va. Lancet 343:1361, 1994
7. Voorberg J, Roelse J, Koopman R, Buller H, Berends F, ten Cate JW, Mertens K, Van Mourik JA: Association of idiopathic venous thromboembolism with single point mutation at Arg506 of factor V. Lancet 343:1535, 1994
8. Svensson PJ, Dahlback B: Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517, 1994
9. Dahlback B: Physiological anticoagulation. Inherited resistance to activated protein C and venous thromboembolism. J Clin Invest 94:923, 1994
10. Beauchamp NJ, Daly ME, Hampto KK, Cooper PC, Preston E, Peake IR: High prevalence of a mutation in the factor V gene within the UK population: Relationship to activated protein C resistance and familial thrombosis. Br J Haematol 88:219, 1994
11. Rees DC, Cox M, Clegg JB: World distribution of factor V Leiden. Lancet 346:1133, 1995
12. Chan LC, Bourke C, Lam CK, Liu HW, Brookes S, Jenkins V, Pasi J: Lack of activated protein C resistance in healthy Hong Kong Chinese blood donors - Correlation with absence of Arg506-Gln mutation of factor V gene (letter). Thromb Haemost 75:522, 1996
13. Rosing J, Hoekema L, Nicolaes GA, Thomassen MC, Hemker HC, Varadi K, Schwarz HP, Tans G: Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem 270:27852, 1995
14. Gandrille S, Greengard JS, Alhenc-Gelas M, Juan-Vague I, Abgrall JF, Jude B, Griffin JH, Aiach M, and the French Network on the behalf of INSERM: Incidence of activated protein C resistance caused by the Arg 506 Gln mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. Blood 86:219, 1995
15. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP: Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. N Engl J Med 332:912, 1995
16. Fujimura H, Kambayashi J, Monden M, Kato H, Miyata T: Coagulation factor V Leiden may have racial background. Thromb Haemostas 74:1379, 1995
17. Kane WH, Ichinose A, Hagen FS, Davie FW: Cloning of cDNAs coding for the heavy chain region and connecting region of human factor V, a blood coagulation factor with four types of internal repeats. Biochemistry 26:6508, 1987
18. Lu D, Kalafatis M, Mann KG, Long GL: Loss of membrane-dependent factor Va cleavage: A mechanistic interpretation of the pathology of protein C Vermont. Blood 84:687, 1994